Ho Lin

4.1k total citations
164 papers, 3.1k citations indexed

About

Ho Lin is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ho Lin has authored 164 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 42 papers in Oncology and 26 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ho Lin's work include Cancer-related Molecular Pathways (18 papers), Hormonal and reproductive studies (10 papers) and Ubiquitin and proteasome pathways (7 papers). Ho Lin is often cited by papers focused on Cancer-related Molecular Pathways (18 papers), Hormonal and reproductive studies (10 papers) and Ubiquitin and proteasome pathways (7 papers). Ho Lin collaborates with scholars based in Taiwan, China and United States. Ho Lin's co-authors include Mei-Chih Chen, Paulus S. Wang, Chih‐Ho Lai, Jer‐Tsong Hsieh, Chih‐Yang Huang, U‐Ging Lo, Shih-Lan Hsu, Tsung‐Ying Yang, Hsin‐Yi Wang and Chun‐Jung Lin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Ho Lin

160 papers receiving 3.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ho Lin 1.4k 702 510 403 310 164 3.1k
Fang Xia 1.7k 1.2× 530 0.8× 410 0.8× 385 1.0× 206 0.7× 124 3.2k
Akira Kondo 1.3k 0.9× 461 0.7× 485 1.0× 251 0.6× 262 0.8× 141 3.5k
Huihua Li 2.1k 1.5× 683 1.0× 454 0.9× 472 1.2× 180 0.6× 106 4.1k
Bandana Chatterjee 1.8k 1.3× 593 0.8× 507 1.0× 346 0.9× 845 2.7× 97 3.7k
Eric A.G. Blomme 1.2k 0.9× 506 0.7× 288 0.6× 266 0.7× 581 1.9× 77 3.3k
Takahito Kondo 1.4k 1.0× 464 0.7× 282 0.6× 157 0.4× 203 0.7× 120 3.2k
Fajun Yang 2.4k 1.7× 523 0.7× 383 0.8× 609 1.5× 278 0.9× 55 4.5k
Shujuan Chen 2.2k 1.6× 835 1.2× 367 0.7× 422 1.0× 87 0.3× 91 3.7k
Evi Schmid 1.4k 1.0× 415 0.6× 340 0.7× 209 0.5× 140 0.5× 74 3.0k
Maqbool Ahmed 1.5k 1.1× 607 0.9× 218 0.4× 474 1.2× 157 0.5× 81 2.8k

Countries citing papers authored by Ho Lin

Since Specialization
Citations

This map shows the geographic impact of Ho Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ho Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ho Lin more than expected).

Fields of papers citing papers by Ho Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ho Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ho Lin. The network helps show where Ho Lin may publish in the future.

Co-authorship network of co-authors of Ho Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Ho Lin. A scholar is included among the top collaborators of Ho Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ho Lin. Ho Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, I‐Chieh, Yi‐Ming Chen, Tzu‐Hung Hsiao, et al.. (2024). Using a Polygenic Risk Score to Improve the Risk Prediction of Non–Small Cell Lung Cancer in Taiwan. JCO Precision Oncology. 8(8). e2400236–e2400236. 2 indexed citations
3.
Huang, Yen-Hsiang, Kun‐Chieh Chen, Kuo-Hsuan Hsu, et al.. (2022). Reactivation of Hepatitis B Virus in Lung Cancer Patients Receiving Tyrosine Kinase Inhibitor Treatment. Journal of Clinical Medicine. 12(1). 231–231. 6 indexed citations
4.
Chen, Yuan, et al.. (2022). Developing New Treatment Options for Castration-Resistant Prostate Cancer and Recurrent Disease. Biomedicines. 10(8). 1872–1872. 11 indexed citations
5.
Huang, Yen-Hsiang, Ho Lin, Kuo-Hsuan Hsu, et al.. (2022). Histological Transformation after Acquired Resistance to the Third-Generation EGFR-TKI in Patients with Advanced EGFR-Mutant Lung Adenocarcinoma. Medicina. 58(7). 908–908. 4 indexed citations
6.
Chen, Mei-Chih, Chieh‐Lin Jerry Teng, Hsin‐Yi Wang, et al.. (2021). RET Regulates Human Medullary Thyroid Cancer Cell Proliferation through CDK5 and STAT3 Activation. Biomolecules. 11(6). 860–860. 13 indexed citations
7.
Yuan, Chen, Hui-Yu Wu, Yu‐Fang Chang, et al.. (2021). Bacterial Genotoxin-Coated Nanoparticles for Radiotherapy Sensitization in Prostate Cancer. Biomedicines. 9(2). 151–151. 11 indexed citations
8.
Lin, Ho, et al.. (2020). Usefulness of Inflammation-Based Prognostic Scores for Predicting the Risk of Complications After Radical Resection of Colorectal Carcinoma. SHILAP Revista de lepidopterología. 1 indexed citations
9.
Gao, Zhenhai, Chun Song, Li G, et al.. (2019). Pyrotinib treatment on HER2-positive gastric cancer cells promotes the released exosomes to enhance endothelial cell progression, which can be counteracted by apatinib. SHILAP Revista de lepidopterología. 3 indexed citations
10.
Lin, Eugene, Mei-Chih Chen, G. M. Shazzad Hossain Prince, et al.. (2019). Future Aspects of CDK5 in Prostate Cancer: From Pathogenesis to Therapeutic Implications. International Journal of Molecular Sciences. 20(16). 3881–3881. 23 indexed citations
11.
Chen, Mei-Chih, Chang-Tze Ricky Yu, Chieh‐Lin Jerry Teng, et al.. (2019). Arecoline Promotes Migration of A549 Lung Cancer Cells through Activating the EGFR/Src/FAK Pathway. Toxins. 11(4). 185–185. 29 indexed citations
12.
Yun, Eun-Jin, Andrew Dang, Jiaming Guo, et al.. (2019). Downregulation of Human DAB2IP Gene Expression in Renal Cell Carcinoma Results in Resistance to Ionizing Radiation. Clinical Cancer Research. 25(14). 4542–4551. 22 indexed citations
13.
Chen, Yuan, David T.W. Tzeng, Yi‐Ping Huang, et al.. (2018). Antrocin Sensitizes Prostate Cancer Cells to Radiotherapy through Inhibiting PI3K/AKT and MAPK Signaling Pathways. Cancers. 11(1). 34–34. 45 indexed citations
14.
Lin, Ho, et al.. (2017). Effect of different blood glucose intervention plans on elderly people with type 2 diabetes mellitus combined with dementia.. PubMed. 21(11). 2702–2707. 9 indexed citations
15.
Chen, Mei-Chih, Chih‐Hsiang Chang, Chih‐Ho Lai, et al.. (2016). Cdk5 Directly Targets Nuclear p21CIP1 and Promotes Cancer Cell Growth. Cancer Research. 76(23). 6888–6900. 32 indexed citations
16.
Lin, Eugene C., et al.. (2014). All-Trans Retinoic Acid Induces DU145 Cell Cycle Arrest through Cdk5 Activation. Cellular Physiology and Biochemistry. 33(6). 1620–1630. 25 indexed citations
18.
Lin, Ho, et al.. (2008). Large Epidermoid Cyst of the Breast: Report of a Case. Formosan Journal of Surgery. 41(5). 221–225.
19.
Lin, Ho, et al.. (1998). A New Extraction and Purification Method for Phycocyanins from Spirulina.. 15(1). 18–20. 2 indexed citations
20.
Lin, Ho. (1991). HILBERT C~*-MODULES AND THEIR BOUNDED MODULE MAPS. 中国科学A辑(英文版). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026